FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 1, 2001, Pages 48-56

  Takahashi, Satoru ^a   Keto, Yoshihiro ^a   Fujita, Takuya ^a   Uchiyama, Tomomi ^a   Yamamoto, Akira ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHEMOKINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EROSIVE GASTRITIS; GERBIL; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; MALE; MUCOSA INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH MUCOSA;

ANIMALS; CELL LINE; CHEMOKINES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENZYME ACTIVATION; ENZYME INHIBITORS; GASTRIC MUCOSA; GASTRITIS; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOENZYMES; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; PYRIDINES; RATS;

EID: 0035201877     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
2. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation
3. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB203580 and PD98059: SB203580 also inhibits thromboxane synthase
4. Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage
5. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa
6. Expression of interleukin-8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro
7. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
8. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: Comparison with nonsteroidal anti-inflammatory drugs
9. Eicosanoids and the gastrointestinal tract
10. How does Helicobacter pylori cause mucosal damage? The inflammatory response
11. The activation state of p38 MAPK determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding
12. Mechanism by which indomethacin delays the healing of acetic acid-induced ulcers in rats. Role of neutrophil antichemotactic and chemotactic activities
13. Influence of FR167653, an inhibitor of TNF-α and IL-1, on the cardiovascular responses to chronic infusion of lipopolysaccharide in conscious rats
14. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB203580, by alteration of one or more amino acids within the ATP binding pocket
15. The role of p38 MAP kinase in TGF-β1-induced signal transduction in human neutrophils
16. Pharmacological effects of SB220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models
17. The effects of FR167653 on pulmonary ischemia-reperfusion injury in dogs
18. Cytokine receptor signaling mechanisms
19. Comparison of suppressive effects of a new anti-inflammatory compound, FR167653, on production of PGE2 and inflammatory cytokines, human monocytes, and alveolar macrophages in response to endotoxin
20. - Helicobacter pylori
21. Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils. Combined treatment with omeprazole and clarithromycin
22. The effects of FR167653 in extended liver resection with ischemia in dogs
23. Effects of FR167653 on ischemia-reperfusion injury: Evaluation through preservation and transplantation in canine hearts
24. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles
25. Bicyciic imidazoles as a novel class of cytokine biosynthesis inhibitors
26. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
27. Cyclo-oxygenase-2: Pharmacology, physiology, biochemistry and relevance to NSAID therapy
28. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP
29. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection
30. The Sydney system: Histological division
31. Pathological changes in the formation of Helicobacter pylori-induced gastric lesions in Mongolian gerbils
32. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats
33. Infiltration of neutrophils by intrapleural injection of tumor necrosis factor, interleukin-1, and interleukin-8 in rats, its modification by actinomycin D
34. RWJ67657, a potent, orally active inhibitor of p36 mitogen-activated protein kinase
35. Chemoattractants for neutrophils in lipopolysaccharide-induced inflammatory exudate from rats are not interleukin-8 counterparts but gro-gene-product/melanoma-growth-stimulating-activity-related factors
36. Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation
37. FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-α, ameliorates endotoxin-induced shock
38. Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection
39. Tumor necrosis factor a and interferon γ synergistically induce interleukin-8 production in a human gastric cancer ceil line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene
40. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation